BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar R, Murugan NA, Srivastava V. Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence. Int J Mol Sci 2022;23:3409. [PMID: 35328828 DOI: 10.3390/ijms23063409] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Gu C, Ruan Z, Tang M. Competition of SARS-CoV-2 variants on the pandemic transmission dynamics. Chaos Solitons Fractals 2023;169:113193. [PMID: 36817403 DOI: 10.1016/j.chaos.2023.113193] [Reference Citation Analysis]
2 Singh JK, Anand S, Srivastava SK. Is BF.7 more infectious than other Omicron subtypes: Insights from structural and simulation studies of BF.7 spike RBD variant. Int J Biol Macromol 2023;:124154. [PMID: 36965551 DOI: 10.1016/j.ijbiomac.2023.124154] [Reference Citation Analysis]
3 Marko Popovic. SARS-CoV-2 strain wars continues: Chemical and thermodynamic characterization of live matter and biosynthesis of Omicron BN.1, CH.1.1 and XBC variants. Microb Risk Anal 2023:100260. [ DOI: 10.1016/j.mran.2023.100260] [Reference Citation Analysis]
4 Mezhibovsky E, Hoang SH, Szeto S, Roopchand DE. In silico analysis of dietary polyphenols and their gut microbial metabolites suggest inhibition of SARS-CoV-2 infection, replication, and host inflammatory mediators. J Biomol Struct Dyn 2023;:1-19. [PMID: 36803516 DOI: 10.1080/07391102.2023.2180669] [Reference Citation Analysis]
5 Shiraz R, Tripathi S. Enhanced recombination among Omicron subvariants of SARS-CoV-2 contributes to viral immune escape. J Med Virol 2023;95:e28519. [PMID: 36691935 DOI: 10.1002/jmv.28519] [Reference Citation Analysis]
6 Liu X, Jiang L, Li L, Lu F, Liu F. Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions. Heliyon 2023;9:e12890. [PMID: 36686609 DOI: 10.1016/j.heliyon.2023.e12890] [Reference Citation Analysis]
7 Boonserm P, Khunrae P, Sutthibutpong T. A computational study on the molecular mechanisms of panduratin A as a potential inhibitor on SARS-CoV-2 protein targets. Heliyon 2023;9:e12780. [PMID: 36628324 DOI: 10.1016/j.heliyon.2022.e12780] [Reference Citation Analysis]
8 Szpulak A, Garlak U, Ćwirko H, Witkowska B, Rombel-Bryzek A, Witkowska D. SARS-CoV-2 and its impact on the cardiovascular and digestive systems - The interplay between new virus variants and human cells. Comput Struct Biotechnol J 2023;21:1022-9. [PMID: 36694807 DOI: 10.1016/j.csbj.2023.01.024] [Reference Citation Analysis]
9 Carter C, Airas J, Parish CA. Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493. J Mol Graph Model 2023;118:108360. [PMID: 36401897 DOI: 10.1016/j.jmgm.2022.108360] [Reference Citation Analysis]
10 Lu X, Chen Y, Zhang G. Functional evolution of SARS-CoV-2 spike protein: Maintaining wide host spectrum and enhancing infectivity via surface charge of spike protein. Comput Struct Biotechnol J 2023;21:2068-74. [PMID: 36936817 DOI: 10.1016/j.csbj.2023.03.010] [Reference Citation Analysis]
11 Raj Kumar Chinnadurai, Saravanaraman Ponne, Loganathan Chitra, Rajender Kumar, Palvannan Thayumanavan, Balanehru Subramanian. Pharmacoinformatic approach to identify potential phytochemicals against SARS-CoV-2 spike receptor-binding domain in native and variants of concern. Mol Divers 2022. [PMID: 36547813 DOI: 10.1007/s11030-022-10580-9] [Reference Citation Analysis]
12 Zappa M, Verdecchia P, Angeli F. Knowing the new Omicron BA.2.75 variant ('Centaurus'): A simulation study. Eur J Intern Med 2022;105:107-8. [PMID: 35981914 DOI: 10.1016/j.ejim.2022.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
13 Pitsillou E, Liang JJ, Beh RC, Hung A, Karagiannis TC. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain. Computers in Biology and Medicine 2022;149:106035. [DOI: 10.1016/j.compbiomed.2022.106035] [Reference Citation Analysis]
14 Verkhivker G, Agajanian S, Kassab R, Krishnan K. Atomistic Simulations and Network-Based Energetic Profiling of Binding and Allostery in the SARS-CoV-2 Spike Omicron BA.1, BA.1.1, BA.2 and BA.3 Subvariant Complexes with the Host Receptor: Revealing Hidden Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Long-Range Communication with Allosteric Pockets.. [DOI: 10.1101/2022.09.05.506698] [Reference Citation Analysis]
15 Shiraz R, Tripathi S. Enhanced Recombination Among SARS-CoV-2 Omicron Variants Contributes to Viral Immune Escape.. [DOI: 10.1101/2022.08.23.504936] [Reference Citation Analysis]
16 Paul S, Nadendla S, Sobhia ME. Identification of Potential ACE2-Derived Peptide Mimetics in SARS-CoV-2 Omicron Variant Therapeutics using Computational Approaches. J Phys Chem Lett 2022;:7420-8. [PMID: 35929665 DOI: 10.1021/acs.jpclett.2c01155] [Reference Citation Analysis]
17 Giron CC, Laaksonen A, Barroso da Silva FL. Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2095305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 da Costa CHS, de Freitas CAB, Alves CN, Lameira J. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants. Sci Rep 2022;12:8540. [PMID: 35595778 DOI: 10.1038/s41598-022-12479-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]